Effect of Secondary Prophylaxis on the Risk of Recurrent Cytomegalovirus Infection Among Solid Organ Transplant Recipients

Valcyte (valganciclovir) - Roche, Mitsubishi Tanabe

Prevymis (letermovir) - Merck (MSD)

Livtencity (maribavir) - Takeda, GSK

M. Vega Brizneda 1; A. Khazan 1; D. Newell 2; H. Wang 3; C. Koval 1; Z. A. Yetmar 1

Jul 30, 2025